Ajanta Pharma Share price target & analyst calls
₹3,270.6+10.40 (+0.32%)
As of 22 Oct 2026
Avg 1-year target
All 3 long-term calls are BUY₹4,109.6725.7% above today's price
Ajanta Pharma's average 1-year share price target is ₹4,109.67, the average of 3 advisors' latest targets. Targets range from ₹3,829 to ₹4,500.
Latest: Rakesh Bansal ₹4,500 · 10 Aug 2026
3
3 BUY · 0 SELL, all horizons
3
with an active 1Y target
61%
22 of 36 closed calls hit
39
all horizons, open and closed
Watch AJANTPHARM for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Ajanta Pharma target price by brokerage
Each advisor's latest 1-year target · 3 advisors · tap a row for the call
All tips (39)
RBbyRakesh Bansal+37.6% to target
1 Year · 10 mo left · 10 Aug 2026 · entry ₹3,495.9 · via Zee Business (Live)P&L -6.4%
MObyMotilal Oswal+22.3% to target
1 Year* · 9 mo left · 30 Jul 2026 · entry ₹3,436.4 · via Moneycontrol Broker ResearchP&L -4.8%
SSbySystematix Shares & Stock+17.1% to target
1 Year* · 9 mo left · 7 Jul 2026 · entry ₹3,374 · via Economic Times New Stock RecosP&L -3.1%
PHbyPradeep Haldar, PHD CapitalTarget hit
1 Year · 31 Jul 2026 · entry ₹3,436.2 · via Business Todayexit ₹3,750
PLbyPrabhudas LilladherTarget hit
1 Year* · 31 Jul 2026 · entry ₹3,465.2 · via Moneycontrol Broker Researchexit ₹3,730
PLbyPrabhudas LilladherTarget hit
1 Year* · 6 May 2026 · entry ₹3,096.3 · via Institutional / Brokerage Researchexit ₹3,400
ISbyICICI SecuritiesTarget hit
1 Year* · 6 May 2026 · entry ₹3,096.3 · via Institutional / Brokerage Researchexit ₹3,520
BCbyBOB Capital MarketsTarget hit
1 Year* · 6 May 2026 · entry ₹3,096.3 · via Institutional / Brokerage Researchexit ₹3,347
ISbyICICI SecuritiesTarget hit
1 Year* · 1 Feb 2026 · entry ₹2,807 · via Institutional / Brokerage Researchexit ₹3,270
MObyMotilal OswalTarget hit
1 Year* · 30 Jan 2026 · entry ₹2,781.9 · via Institutional / Brokerage Researchexit ₹3,400
MObyMotilal OswalTarget hit
1 Year* · 29 Dec 2025 · entry ₹2,690.2 · via Institutional / Brokerage Researchexit ₹3,145
ISbyICICI SecuritiesTarget hit
1 Year* · 4 Nov 2025 · entry ₹2,610.7 · via Institutional / Brokerage Researchexit ₹3,000
MObyMotilal OswalTarget hit
1 Year* · 3 Nov 2025 · entry ₹2,539.4 · via Institutional / Brokerage Researchexit ₹3,000
ISbyICICI SecuritiesTarget hit
1 Year* · 1 May 2025 · entry ₹2,686.1 · via Institutional / Brokerage Researchexit ₹2,500
BCbyBOB Capital MarketsTarget hit
1 Year* · 11 Dec 2024 · entry ₹2,793.7 · via Institutional / Brokerage Researchexit ₹2,528
ISbyICICI SecuritiesTarget hit
1 Year* · 31 Jul 2024 · entry ₹2,695.1 · via Institutional / Brokerage Researchexit ₹3,165
MObyMotilal OswalTarget hit
1 Year* · 30 Jul 2024 · entry ₹2,530.55 · via Institutional / Brokerage Researchexit ₹2,935
BCbyBOB Capital MarketsTarget hit
1 Year* · 3 May 2024 · entry ₹2,383.85 · via Institutional / Brokerage Researchexit ₹2,585
ISbyICICI SecuritiesTarget hit
1 Year* · 3 May 2024 · entry ₹2,383.85 · via Institutional / Brokerage Researchexit ₹2,875
MObyMotilal OswalTarget hit
1 Year* · 2 May 2024 · entry ₹2,234 · via Institutional / Brokerage Researchexit ₹2,565
BCbyBOB Capital MarketsExpired
1 Year* · 31 Jan 2025 · entry ₹2,694.45 · via Institutional / Brokerage Researchexit ₹2,781.9
MObyMotilal OswalExpired
1 Year* · 30 Jan 2025 · entry ₹2,676.85 · via Institutional / Brokerage Researchexit ₹2,781.9
ISbyICICI SecuritiesExpired
1 Year* · 11 Nov 2024 · entry ₹2,857.3 · via Institutional / Brokerage Researchexit ₹2,577.6
MObyMotilal OswalExpired
1 Year* · 28 Oct 2024 · entry ₹2,922.6 · via Institutional / Brokerage Researchexit ₹2,388.4
KJbyKiran Jani, Jainam BrokingTarget hit
1–3 Months · 26 May 2026 · entry ₹3,100.4 · via Business Todayexit ₹3,600
SMbySomil Mehta, SharekhanTarget hit
1–2 Weeks* · 11 May 2026 · entry ₹3,082.2 · via CNBC Awaaz.exit ₹3,300
SRbySahi ResearchStop-loss hit
1–2 Weeks* · 24 Sept 2026 · entry ₹3,569 · via Sahi Research Telegramexit ₹3,450
SRbySiddharth Rai MangalaStop-loss hit
1–2 Weeks* · 18 Sept 2026 · entry ₹3,594 · via Zee Business (Live)exit ₹3,540
KSbyKshitija Salvi, Globe Capital MarketStop-loss hit
1–2 Weeks* · 8 Sept 2026 · entry ₹3,568 · via CNBC Awaaz.exit ₹3,471
KBbyKush BohraStop-loss hit
1–2 Weeks* · 17 Aug 2026 · entry ₹3,691.1 · via NDTV Profit (Live)exit ₹3,590
KBbyKush BohraStop-loss hit
1–2 Weeks* · 14 Aug 2026 · entry ₹3,620.9 · via NDTV Profit (Live)exit ₹3,520
AJbyAastha Jain, Hem SecuritiesStop-loss hit
BTST · 30 Sept 2026 · entry ₹3,621.6 · via Zee Business (Live)exit ₹3,566
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.6% · 19 calls
- CIPLACipla Ltd.₹1,524+14.5% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+26.6% · 15 calls
- BIOCONBiocon Ltd₹485+46.9% · 12 calls
- LUPINLupin Limited₹2,576+34.1% · 12 calls
- AJANTPHARM· this stockAjanta Pharma Limited₹4,110+25.7% · 3 calls